Gessain A, Cassar O (2012) Epidemiological aspects and world distribution of HTLV-1 infection. Front Microbiol 15(3):388. https://doi.org/10.3389/fmicb.2012.00388

Article  Google Scholar 

Rafatpanah H, Hedayati-Moghaddam MR, Fathimoghadam F, Bidkhori HR, Shamsian SK, Ahmadi S, Sohgandi L, Azarpazhooh MR, Rezaee SA, Farid R, Bazarbachi A (2011) High prevalence of HTLV-I infection in Mashhad, Northeast Iran: a population-based seroepidemiology survey. J Clin Virol 52(3):172–176. https://doi.org/10.1016/j.jcv.2011.07.004

Article  PubMed  Google Scholar 

Nozuma S, Kubota R, Jacobson S (2020) Human T-lymphotropic virus type 1 (HTLV-1) and cellular immune response in HTLV-1-associated myelopathy/tropical spastic paraparesis. J Neurovirol 26(5):652–663. https://doi.org/10.1007/s13365-020-00881-w

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mohammadi A, Fazeli B, Poursina Z, Tehranian F, Vakili V, Boostani R, Rafatpanah H (2019) HTLV-1-infected asymptomatic carriers compared to HAM/TSP patients over-express the apoptosis- and cytotoxicity-related molecules. Med Microbiol Immunol 208(6):835–844. https://doi.org/10.1007/s00430-019-00625-6

Article  PubMed  Google Scholar 

Gudo ES, Silva-Barbosa SD, Linhares-Lacerda L, Ribeiro-Alves M, Real SC, Bou-Habib DC, Savino W (2015) HAM/TSP-derived HTLV-1-infected T cell lines promote morphological and functional changes in human astrocytes cell lines: possible role in the enhanced T cells recruitment into central nervous system. Virol J 12(12):165. https://doi.org/10.1186/s12985-015-0398-x

Article  CAS  PubMed  PubMed Central  Google Scholar 

Freitas NL, Gomes YCP, Souza FDS, Torres RC, Echevarria-Lima J, Leite ACCB, Lima MASD, Araújo AQC, Silva MTT, Espíndola OM (2022) Lessons from the cerebrospinal fluid analysis of HTLV-1-infected individuals: biomarkers of inflammation for HAM/TSP development. Viruses 14(10):2146. https://doi.org/10.3390/v14102146

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lopes Martins AL, Rios Grassi MF, de Aquino FA, Lacerda Araujo JP, Paixao TS, Galvão-Castro B, Boa-Sorte N (2018) Human T-lymphotropic virus-1-associated myelopathy/tropical spastic paraparesis is associated with sexual dysfunction in infected women of reproductive age. Sex Med 6(4):324–331. https://doi.org/10.1016/j.esxm.2018.07.002. (Epub 2018 Sep 1)

Article  PubMed  PubMed Central  Google Scholar 

Hatatian N, Bosstani R, Mohammadi A, Mehraban S, Mahdifar M, Zemorshidi F, Mozhgani SH, Haji Ghadimi A, Foroughipour M, Rafatpanah H (2021) Evaluation of interleukin-32 and cyclooxygenase-2 expression in HAM/TSP patients and HTLV-1 asymptomatic carriers. Iran J Basic Med Sci 24(7):992–996. https://doi.org/10.22038/ijbms.2021.50821.11569

Article  PubMed  PubMed Central  Google Scholar 

Guerra M, Luna T, Souza A, Amorim C, Carvalho NB, Carvalho L, Tanajura D, Cardoso LS, Carvalho EM, Santos S (2018) Local and systemic production of proinflammatory chemokines in the pathogenesis of HAM/TSP. Cell Immunol 334:70–77. https://doi.org/10.1016/j.cellimm.2018.09.009

Article  CAS  PubMed  Google Scholar 

Souza FDS, Freitas NL, Gomes YCP, Torres RC, Echevarria-Lima J, da Silva-Filho IL, Leite ACCB, de Lima MASD, da Silva MTT, Araújo AQC, Espíndola OM. Following the clues: usefulness of biomarkers of neuroinflammation and neurodegeneration in the investigation of HTLV-1-associated myelopathy progression. Front Immunol. 2021;12:737941. https://doi.org/10.3389/fimmu.2021.737941

Yi L, Tang J, Shi C, Zhang T, Li J, Guo F, Zhang W (2020) Pentraxin 3, TNF-α, and LDL-C are associated with carotid artery stenosis in patients with ischemic stroke. Front Neurol 10(10):1365. https://doi.org/10.3389/fneur.2019.01365

Article  PubMed  PubMed Central  Google Scholar 

Qi S, Zhao F, Li Z, Liang F, Yu S (2020) Silencing of PTX3 alleviates LPS-induced inflammatory pain by regulating TLR4/NF-κB signaling pathway in mice. Biosci Rep 40(2):BSR20194208. https://doi.org/10.1042/BSR20194208

Ummenthum K, Peferoen LA, Finardi A, Baker D, Pryce G, Mantovani A, Bsibsi M, Bottazzi B, Peferoen-Baert R, van der Valk P, Garlanda C, Kipp M, Furlan R, van Noort JM, Amor S (2016) Pentraxin-3 is upregulated in the central nervous system during MS and EAE, but does not modulate experimental neurological disease. Eur J Immunol 46(3):701–711. https://doi.org/10.1002/eji.201545950

Article  CAS  PubMed  Google Scholar 

Moalli F, Paroni M, Véliz Rodriguez T, Riva F, Polentarutti N, Bottazzi B, Valentino S, Mantero S, Nebuloni M, Mantovani A, Bragonzi A, Garlanda C (2011) The therapeutic potential of the humoral pattern recognition molecule PTX3 in chronic lung infection caused by Pseudomonas aeruginosa. J Immunol 186(9):5425–5434. https://doi.org/10.4049/jimmunol.1002035

Article  CAS  PubMed  Google Scholar 

Rodriguez-Grande B, Varghese L, Molina-Holgado F, Rajkovic O, Garlanda C, Denes A, Pinteaux E (2015) Pentraxin 3 mediates neurogenesis and angiogenesis after cerebral ischaemia. J Neuroinflamm 24(12):15. https://doi.org/10.1186/s12974-014-0227-y

Article  CAS  Google Scholar 

Polentarutti N, Bottazzi B, Di Santo E, Blasi E, Agnello D, Ghezzi P, Introna M, Bartfai T, Richards G, Mantovani A (2000) Inducible expression of the long pentraxin PTX3 in the central nervous system. J Neuroimmunol 106(1–2):87–94. https://doi.org/10.1016/s0165-5728(00)00214-9

Article  CAS  PubMed  Google Scholar 

Ravizza T, Moneta D, Bottazzi B, Peri G, Garlanda C, Hirsch E, Richards GJ, Mantovani A, Vezzani A (2001) Dynamic induction of the long pentraxin PTX3 in the CNS after limbic seizures: evidence for a protective role in seizure-induced neurodegeneration. Neuroscience 105(1):43–53. https://doi.org/10.1016/s0306-4522(01)00177-4

Article  CAS  PubMed  Google Scholar 

Lee HW, Choi J, Suk K (2011) Increases of pentraxin 3 plasma levels in patients with Parkinson’s disease. Mov Disord 26(13):2364–2370. https://doi.org/10.1002/mds.23871

Article  PubMed  Google Scholar 

Bourgeois MA, Denslow ND, Seino KS, Barber DS, Long MT (2011) Gene expression analysis in the thalamus and cerebrum of horses experimentally infected with West Nile virus. PLoS ONE 6(10):e24371. https://doi.org/10.1371/journal.pone.0024371

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zatta M, Di Bella S, Bottazzi B, Rossi F, D’Agaro P, Segat L, Fabbiani M, Mantovani A, Luzzati R (2020) Determination of pentraxin 3 levels in cerebrospinal fluid during central nervous system infections. Eur J Clin Microbiol Infect Dis 39(4):665–670. https://doi.org/10.1007/s10096-019-03767-w

Article  CAS  PubMed  Google Scholar 

Paternostro-Sluga T, Grim-Stieger M, Posch M, Schuhfried O, Vacariu G, Mittermaier C, Bittner C, Fialka-Moser V (2008) Reliability and validity of the Medical Research Council (MRC) scale and a modified scale for testing muscle strength in patients with radial palsy. J Rehabil Med 40(8):665–671. https://doi.org/10.2340/16501977-0235

Article  PubMed  Google Scholar 

Charalambous CP (2014) Interrater reliability of a modified Ashworth scale of muscle spasticity. Classic papers in orthopaedics. Springer, Berlin, pp 415–417

Izumo S, Usuku K, Osame M, Arimura K, Igata A (1988) Effect of alpha-interferon treatment on HTLV-I associated myelopathy (HAM). Neurology 39(Suppl 1):242

Google Scholar 

Ramezani S, Shirdel A, Rafatpanah H, Akbarin MM, Tarokhian H, Rahimi H, Bari A, Jahantigh HR, Rezaee SA (2017) Assessment of HTLV-1 proviral load, LAT, BIM, c-FOS and RAD51 gene expression in adult T cell leukemia/lymphoma. Med Microbiol Immunol 206(4):327–335. https://doi.org/10.1007/s00430-017-0506-1

Article  CAS  PubMed  Google Scholar 

Staubli SM, Schäfer J, Rosenthal R, Zeindler J, Oertli D, Nebiker CA (2019) The role of CRP and Pentraxin 3 in the prediction of systemic inflammatory response syndrome and death in acute pancreatitis. Sci Rep 9(1):18340. https://doi.org/10.1038/s41598-019-54910-8

Article  CAS  PubMed  PubMed Central  Google Scholar 

Shoeibi A, Rafatpanah H, Azarpazhooh A, Mokhber N, Hedayati-Moghaddam MR, Amiri A, Hashemi P, Foroghipour M, Hoseini RF, Bazarbachi A, Azarpazhooh MR (2013) Clinical features of HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) in northeast Iran. Acta Neurol Belg 113(4):427–433. https://doi.org/10.1007/s13760-013-0194-6

Article  PubMed  Google Scholar 

Bozza S, Bistoni F, Gaziano R, Pitzurra L, Zelante T, Bonifazi P, Perruccio K, Bellocchio S, Neri M, Iorio AM, Salvatori G, De Santis R, Calvitti M, Doni A, Garlanda C, Mantovani A, Romani L (2006) Pentraxin 3 protects from MCMV infection and reactivation through TLR sensing pathways leading to IRF3 activation. Blood 108(10):3387–3396. https://doi.org/10.1182/blood-2006-03-009266

Article  CAS  PubMed  Google Scholar 

Porte R, Davoudian S, Asgari F, Parente R, Mantovani A, Garlanda C, Bottazzi B (2019) The long pentraxin PTX3 as a humoral innate immunity functional player and biomarker of infections and sepsis. Front Immunol 12(10):794. https://doi.org/10.3389/fimmu.2019.00794

Article  CAS  Google Scholar 

Vengen IT, Enger TB, Videm V, Garred P (2017) Pentraxin 3, ficolin-2 and lectin pathway associated serine protease MASP-3 as early predictors of myocardial infarction—the HUNT2 study. Sci Rep 20(7):43045. https://doi.org/10.1038/srep43045

Article  CAS  Google Scholar 

Oggioni M, Mercurio D, Minuta D, Fumagalli S, Popiolek-Barczyk K, Sironi M, Ciechanowska A, Ippati S, De Blasio D, Perego C, Mika J, Garlanda C, De Simoni MG (2021) Long pentraxin PTX3 is upregulated systemically and centrally after experimental neurotrauma, but its depletion leaves unaltered sensorimotor deficits or histopathology. Sci Rep 11(1):9616. https://doi.org/10.1038/s41598-021-89032-7

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang H, Wang K, Wang C, Zhong X, Qiu W, Hu X (2013) Increased plasma levels of pentraxin 3 in patients with multiple sclerosis and neuromyelitis optica. Mult Scler 19(7):926–931. https://doi.org/10.1177/1352458512457845

Article  CAS  PubMed  Google Scholar 

Ryu WS, Kim CK, Kim BJ, Kim C, Lee SH, Yoon BW (2012) Pentraxin 3: a novel and independent prognostic marker in ischemic stroke. Atherosclerosis 220(2):581–586. https://doi.org/10.1016/j.atherosclerosis.2011.11.036

Article  CAS  PubMed  Google Scholar 

Mauri T, Bellani G, Patroniti N, Coppadoro A, Peri G, Cuccovillo I, Cugno M, Iapichino G, Gattinoni L, Pesenti A, Mantovani A (2010) Persisting high levels of plasma pentraxin 3 over the first days after severe sepsis and septic shock onset are associated with mortality. Intensive Care Med 36(4):621–629. https://doi.org/10.1007/s00134-010-1752-5

Article  CAS  PubMed  Google Scholar 

Ciancarella V, Lembo-Fazio L, Paciello I, Bruno AK, Jaillon S, Berardi S, Barbagallo M, Meron-Sudai S, Cohen D, Molinaro A, Rossi G, Garlanda C, Bernardini ML (2018) Role of a fluid-phase PRR in fighting an intracellular pathogen: PTX3 in Shigella infection. PLoS Pathog 14(12):e1007469. https://doi.org/10.1371/journal.ppat.1007469

Article  CAS  PubMed  PubMed Central  Google Scholar